Mostafa M. Elbadawi

468 citations

17 papers · 378 indexed · h-index 13

Co-authors: Wagdy M. Eldehna Claudiu T. Supuran Alessio Nocentini Hatem A. Abdel‐Aziz Manabu Abe Ahmed I. Khodair Yves Pommier Keli Agama
Topics: Enzyme function and inhibition (8 papers)Synthesis and Catalytic Reactions (8 papers)Synthesis and biological activity (4 papers)
Cited by: Organic Chemistry Toxicology Molecular Biology
Journals: Journal of Medicinal Chemistry European Journal of Medicinal Chemistry Journal of Molecular Structure
Partner nations: Egypt Saudi Arabia Italy

In The Last Decade

Mostafa M. Elbadawi

14 papers receiving 376 citations

Peers

Countries citing papers authored by Mostafa M. Elbadawi

Since Specialization

Citations

This map shows the geographic impact of Mostafa M. Elbadawi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mostafa M. Elbadawi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mostafa M. Elbadawi more than expected).

Fields of papers citing papers by Mostafa M. Elbadawi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mostafa M. Elbadawi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mostafa M. Elbadawi. The network helps show where Mostafa M. Elbadawi may publish in the future.

Co-authorship network of co-authors of Mostafa M. Elbadawi

This figure shows the co-authorship network connecting the top 25 collaborators of Mostafa M. Elbadawi. A scholar is included among the top collaborators of Mostafa M. Elbadawi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mostafa M. Elbadawi. Mostafa M. Elbadawi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Triazole-functionalized benzofuran and benzothiophene semicarbazides as novel VEGFR-2-targeted anti-cancer agents 2025 ·Bioorganic Chemistry ·Mohamed S. Nafie,(unknown),(unknown),Zainab M. Elsayed,Eman F. Khaleel,(unknown),Mohammad M. Al‐Sanea,Mostafa M. Elbadawi,Manabu Abe,Wagdy M. Eldehna,Hatem A. Abdel‐Aziz,Haytham O. Tawfik	3
2	Development of New Pyrazolo [3,4-b]Pyridine Derivatives as Potent Anti-Leukemic Agents and Topoisomerase IIα Inhibitors with Broad-Spectrum Cytotoxicity 2025 ·Pharmaceuticals ·Wagdy M. Eldehna,Haytham O. Tawfik,(unknown),(unknown),(unknown),Zainab M. Elsayed,Taghreed A. Majrashi,(unknown),Mostafa M. Elbadawi,Moataz A. Shaldam,Ghada H. Al-Ansary,Vladimı́r Kryštof,Hatem A. Abdel‐Aziz	0
3	Design, synthesis, and biological evaluation of Benzimidazole–Aminopyrimidine hybrids as selective P38α MAPK inhibitors targeting Neuroinflammation in an AlCl3-induced rat model of Alzheimer's disease 2025 ·Bioorganic Chemistry ·Mohamed Samir,Nader E. Abo‐Dya,Nehal M. Elsherbiny,Kamel Metwally,Riham Abouleisa,Tamer Mohamed,(unknown),(unknown),Mostafa M. Elbadawi,(unknown),(unknown)	0
4	Click Chemistry‐Aided Synthesis of Triazole‐Tethered Benzothiazoles as Novel Multifunctional Agents Against Alzheimer's Disease 2025 ·Archiv der Pharmazie ·Mostafa M. Elbadawi,Abdullah A. Elgazar,(unknown),Maha‐Hamadien Abdulla,Thamer Bin Traiki,(unknown),Mohammad M. Al‐Sanea,Manabu Abe,Wagdy M. Eldehna,Praveen P. N. Rao,Abdelrahman Hamdi	0
5	1,5-Diaryl-1,2,4-triazole Ureas as New SLC-0111 Analogues Endowed with Dual Carbonic Anhydrase and VEGFR-2 Inhibitory Activities 2023 ·Journal of Medicinal Chemistry ·(unknown),Mostafa M. Elbadawi,Alessio Nocentini,Hadia Almahli,Simone Giovannuzzi,Moataz A. Shaldam,Rofaida Salem,Tamer M. Ibrahim,Hatem A. Abdel‐Aziz,Claudiu T. Supuran,Wagdy M. Eldehna	49
6	Development of new thiazolidine-2,4-dione hybrids as aldose reductase inhibitors endowed with antihyperglycaemic activity: design, synthesis, biological investigations, and in silico insights 2023 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·Abdelrahman Hamdi,(unknown),(unknown),M. A. Bhat,Noha I. Ziedan,(unknown),(unknown),Mohamed R. Elnagar,(unknown),(unknown),Abdullah A. Elgazar,(unknown),(unknown),(unknown),Mostafa M. Elbadawi	20
7	Discovery of indolinone-bearing benzenesulfonamides as new dual carbonic anhydrase and VEGFR-2 inhibitors possessing anticancer and pro-apoptotic properties 2023 ·European Journal of Medicinal Chemistry ·(unknown),Moataz A. Shaldam,Mostafa M. Elbadawi,Simone Giovannuzzi,Alessio Nocentini,Hadia Almahli,Rofaida Salem,Tamer M. Ibrahim,Claudiu T. Supuran,Wagdy M. Eldehna	31
8	Design and synthesis of 6-arylpyridine-tethered sulfonamides as novel selective inhibitors of carbonic anhydrase IX with promising antitumor features toward the human colorectal cancer 2023 ·European Journal of Medicinal Chemistry ·Wagdy M. Eldehna,(unknown),Ghada H. Al-Ansary,Emanuela Berrino,Mostafa M. Elbadawi,Tamer M. Ibrahim,(unknown),Sara T. Al‐Rashood,(unknown),(unknown),Alessio Nocentini,Fawzy Elbarbry,Fikrettin Şahιn,Hatem A. Abdel‐Aziz,Claudiu T. Supuran,Mohamed Farès	24
9	Development of 4-((3-oxo-3-phenylpropyl)amino)benzenesulfonamide derivatives utilizing tail/dual-tail approaches as novel carbonic anhydrase inhibitors 2022 ·European Journal of Medicinal Chemistry ·Mostafa M. Elbadawi,Wagdy M. Eldehna,Alessio Nocentini,(unknown),Sara T. Al‐Rashood,Eslam B. Elkaeed,Mahmoud A. El Hassab,Hatem A. Abdel‐Aziz,Claudiu T. Supuran,Mohamed Farès	23
10	Discovery of 2,4-thiazolidinedione-tethered coumarins as novel selective inhibitors for carbonic anhydrase IX and XII isoforms 2022 ·Figshare ·Wagdy M. Eldehna,Mohammed S. Taghour,Tarfah Al‐Warhi,Alessio Nocentini,Mostafa M. Elbadawi,Hazem A. Mahdy,Mohamed A. Abdelrahman,Ohoud J. Alotaibi,Nada Aljaeed,(unknown),Kamyar Afarinkia,Hatem A. Abdel‐Aziz,Claudiu T. Supuran	29
11	Design and synthesis of benzothiazole-based SLC-0111 analogues as new inhibitors for the cancer-associated carbonic anhydrase isoforms IX and XII 2022 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·Tarfah Al‐Warhi,Mostafa M. Elbadawi,Alessandro Bonardi,Alessio Nocentini,Ahmed A. Al‐Karmalawy,Nada Aljaeed,Ohoud J. Alotaibi,Hatem A. Abdel‐Aziz,Claudiu T. Supuran,Wagdy M. Eldehna	40
12	Identification of N-phenyl-2-(phenylsulfonyl)acetamides/propanamides as new SLC-0111 analogues: Synthesis and evaluation of the carbonic anhydrase inhibitory activities 2021 ·European Journal of Medicinal Chemistry ·Mostafa M. Elbadawi,Wagdy M. Eldehna,Alessio Nocentini,Mahmoud F. Abo-Ashour,Eslam B. Elkaeed,Mohamed A. Abdelgawad,Khalid Saad Alharbi,Hatem A. Abdel‐Aziz,Claudiu T. Supuran,Paola Gratteri,Mohammad M. Al‐Sanea	29
13	Discovery of 4-alkoxy-2-aryl-6,7-dimethoxyquinolines as a new class of topoisomerase I inhibitors endowed with potent in vitro anticancer activity 2021 ·European Journal of Medicinal Chemistry ·Mostafa M. Elbadawi,Wagdy M. Eldehna,Wenjie Wang,Keli Agama,Yves Pommier,Manabu Abe	45
14	Design, synthesis and biological evaluation of novel thiohydantoin derivatives as antiproliferative agents: A combined experimental and theoretical assessments 2021 ·Journal of Molecular Structure ·Mostafa M. Elbadawi,Ahmed I. Khodair,Mohamed K. Awad,(unknown),(unknown),Khaled R.A. Abdellatif	23
15	2-Arylquinolines as novel anticancer agents with dual EGFR/FAK kinase inhibitory activity: synthesis, biological evaluation, and molecular modelling insights 2021 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·Mostafa M. Elbadawi,Wagdy M. Eldehna,Amer Ali Abd El‐Hafeez,(unknown),Amgad Albohy,Sara T. Al‐Rashood,Keli Agama,Eslam B. Elkaeed,Pradipta Ghosh,Yves Pommier,Manabu Abe	32
16	Design, Synthesis and Cytotoxicity Evaluation of New 3, 5-Disubstituted-2-Thioxoimidazolidinones 2018 ·Anti-Cancer Agents in Medicinal Chemistry ·Khaled R.A. Abdellatif,Mostafa M. Elbadawi,(unknown),(unknown),Takashi Fujimura,Seiji Kawamoto,Ahmed I. Khodair	17
17	Design, synthesis, molecular docking and cytotoxicity evaluation of some novel 5-arylidene-3-(substituted phenyl)-2-(p-tolylamino)-4-imidazolones 2017 ·Journal of Applied Pharmaceutical Science ·Ahmed I. Khodair,Mostafa M. Elbadawi,(unknown),Khaled R.A. Abdellatif	13

About Mostafa M. Elbadawi

Mostafa M. Elbadawi is a scholar working on Organic Chemistry, Physiology and Pharmacology, having authored 17 papers that have together received 378 indexed citations. Recurring topics across this work include Enzyme function and inhibition (8 papers), Synthesis and Catalytic Reactions (8 papers) and Synthesis and biological activity (4 papers). The work is most often cited by research in Organic Chemistry (307 citations), Toxicology (24 citations) and Molecular Biology (260 citations). Mostafa M. Elbadawi has collaborated with scholars based in Egypt, Saudi Arabia and Italy. Frequent co-authors include Wagdy M. Eldehna, Claudiu T. Supuran, Alessio Nocentini, Hatem A. Abdel‐Aziz, Manabu Abe, Ahmed I. Khodair, Yves Pommier, Keli Agama, Khaled R.A. Abdellatif and Tamer M. Ibrahim. Their work appears in journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry and Journal of Molecular Structure.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact